Our pan-cancer analysis reveals its consistent upregulation in 33 malignancies, including GBM, where it strongly correlates with immunosuppressive molecules (PD-L1, CTLA-4, TGF-β, IL-10), suggesting a potential universal role in immune evasion. This evidence concerns the gene TGFB1 and cancer.